Skip to content
Search

Latest Stories

RPS calls for increased Covid-19 protection for pharmacy teams

The Royal Pharmaceutical Society has joined over 20 other professional bodies and health organisations in demanding that the government and NHS increase Covid-19 protections for healthcare workers including community pharmacy teams.

In a meeting with government, NHS and public health officials on Thursday (June 3), the alliance of these organisations called for the UK infection prevention control guidance to be updated as well as making necessary arrangement for the supply of enhanced PPE for frontline healthcare workers.


“Whilst welcoming the government’s offer of further discussions, the alliance was disappointed that the UK guidance would not be updated at this time, despite emerging evidence and changes to guidance in the US and Europe,” the RPS said, sharing its concern over the safety of community pharmacy teams.

RPS president Sandra Gidley commented: “Supporting pharmacy teams and calling for appropriate PPE has been a key focus for the RPS during the pandemic.

“With frontline health and care staff under continued strain, we owe it to everybody to make sure they get the protection they deserve.

“As our understanding of Covid-19 evolves it’s vital that national guidance and support keep pace.”

The alliance believes that changes to the guidance are essential and should not be delayed. New Covid-19 variants and recent rises in positive cases make the case urgent for healthcare workers to be fully protected and provided with FFP3 masks when seeing patients, the RPS stressed.

More For You

First daily pill for endometriosis to be available on NHS

Instead of travelling to clinics for injections, endometriosis patients can take a daily tablet at home

Getty Images

New endometriosis pill approved for NHS use, but only few patients will benefit

The National Institute for Health and Care Excellence (NICE) has approved a new pill for the treatment of endometriosis, providing hope for thousands of women affected by the debilitating condition.

The pill, called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), is the first long-term daily pill approved for use in the UK to treat endometriosis, and it is expected to help about 1,000 patients every year.

Keep ReadingShow less
​RPS urges its members and fellows to vote in favour of Royal College for “a stronger, louder voice”

The Special Resolution Vote will remain open until 5 p.m. on Thursday, 24 March 2025.

Getty Images

Royal College voting begins: A historic moment in the profession’s evolution

Becoming a royal college will ensure pharmacy profession gains the recognition and authority it deserves, says RPS president Professor Claire Anderson.

Starting today (13), members and fellows of the Royal Pharmaceutical Society (RPS) will begin voting on the proposed changes to its Royal Charter, marking the beginning of a historic shift toward becoming the Royal College of Pharmacy.

Keep ReadingShow less
GPs to play crucial role in transforming Wales’ health service

Jeremy Miles

(Photo credit: www.gov.wales )

Strengthening GPs’ role key to transforming healthcare - Jeremy Miles

Welsh health secretary Jeremy Miles has recognised the need to transform health services and bring healthcare closer to home.

Speaking at the recent Welsh Local Medical Committees Conference, he emphasised that strengthening the role of GPs would be crucial in improving patient healthcare and tackling NHS waiting lists.

Keep ReadingShow less
NPA and IPA urge NHS England to release pharmacy economic analysis immediately

Pharmacy bodies call for transparency on the funding gap amid ongoing contract negotiations.

Getty Images

Pharmacy bodies demand immediate release of economic analysis

The National Pharmacy Association (NPA) and the Independent Pharmacies Association (IPA) have jointly written to NHS England, demanding the immediate release of the independent economic analysis of pharmacy finances commissioned last autumn.

An open letter, signed by the owners of 3,034 pharmacies in England, calls for transparency on the funding gap amid ongoing contract negotiations.

Keep ReadingShow less